← Search

Data · dataset · 2026

<p>Uncropped western blot images in this study.</p>

Listed in ZivaHub and Deakin Research Online and DMU Figshare and UCL Research Data Repository — shown once because both records carry DOI 10.1371/journal.pbio.3003944.s018

<div><p>Sarbecoviruses interact with their receptor, angiotensin-converting enzyme 2 (ACE2), via the receptor-binding domain (RBD) of Spike, the immunodominant target for neutralising antibodies.

Description

Understanding the interplay and correlation between ACE2-determined host range and antigenicity is vitally important for understanding the zoonotic potential of related bat sarbecoviruses. Using binding assays, pseudotype-entry assays and a diverse panel of mammalian ACE2 proteins, we examined the host range and related antigenicity of multiple bat coronaviruses.

Broad bat ACE2 usage (a <i>generalist</i> phenotype) was most common in clade 1 sarbecoviruses, including SARS-CoV-2 and the BANAL isolates from Laos. In contrast, clade 3 (e.g., RhGB07) and 5 (e.g., Rc-o319) sarbecoviruses exhibited more restricted ACE2 usage (a <i>specialist</i> phenotype). A novel structure for RhGB07 Spike further helped to identify RBD residues associated with this receptor specialism.

Read the rest (3 more)

Interestingly, the generalist phenotypes were largely maintained with more diverse mammalian receptor libraries, including human, non-human primate, livestock, rodent ACE2 and potential intermediate reservoir hosts (e.g., civet, racoon dog, pangolin), while specialists, like RhGB07, exhibited wider phenotypic diversity. The impact of SARS-CoV-2’s continued evolution in humans was also examined, identifying an expanding and/or shifting pattern of generalism for variants, especially Omicron and its sub-lineages.

Furthermore, we compared and correlated these entry phenotypes with antigenicity using sera from SARS-CoV-2 convalescent individuals. Clade 1 viruses, phylogenetically related to SARS-CoV-2, were antigenically the most similar, with robust evidence for cross-neutralisation; however, there was still evidence for limited cross-neutralisation across the entire sub-genus. Finally, using monoclonal antibodies, derived from COVID-19 vaccinees with breakthrough infections, we pin-pointed the antibody epitope classes responsible for wider neutralisation.

Our research indicates that generalist ACE2-using sarbecoviruses are phylogenetically and antigenically related to SARS-CoV-2.</p></div>

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Image 65%
Provenance · 4 source records, 50 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3404736412 d agoJSON v1
Deakin Research Onlineoai:figshare.com:article/3404736412 d agoJSON v1
DMU Figshareoai:figshare.com:article/3404736412 d agoJSON v1
UCL Research Data Repositoryoai:figshare.com:article/3404736412 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[disease].local:disease:cancermapping · dro deakin edu auvocabulary-mapper@1.0.0keywords['Cancer']
concepts[disease].local:disease:cancermapping · rdr ucl ac ukvocabulary-mapper@1.0.0keywords['Cancer']
concepts[disease].local:disease:cancermapping · figshare dmu ac ukvocabulary-mapper@1.0.0keywords['Cancer']
concepts[disease].local:disease:cancermapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Cancer']
concepts[field].anzsrc:field:310706mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Virology']
concepts[field].anzsrc:field:310706mapping · dro deakin edu auvocabulary-mapper@1.0.0keywords['Virology']
concepts[field].anzsrc:field:310706mapping · figshare dmu ac ukvocabulary-mapper@1.0.0keywords['Virology']
concepts[field].anzsrc:field:310706mapping · rdr ucl ac ukvocabulary-mapper@1.0.0keywords['Virology']
concepts[field].anzsrc:field:320211mapping · rdr ucl ac ukvocabulary-mapper@1.0.0keywords['Infectious Diseases']
concepts[field].anzsrc:field:320211mapping · figshare dmu ac ukvocabulary-mapper@1.0.0keywords['Infectious Diseases']
concepts[field].anzsrc:field:320211mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Infectious Diseases']
concepts[field].anzsrc:field:320211mapping · dro deakin edu auvocabulary-mapper@1.0.0keywords['Infectious Diseases']
concepts[field].anzsrc:group:3101mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Cell Biology']
concepts[field].anzsrc:group:3101mapping · dro deakin edu auvocabulary-mapper@1.0.0keywords['Cell Biology']
concepts[field].anzsrc:group:3101mapping · figshare dmu ac ukvocabulary-mapper@1.0.0keywords['Cell Biology']
concepts[field].anzsrc:group:3101mapping · rdr ucl ac ukvocabulary-mapper@1.0.0keywords['Cell Biology']
concepts[field].anzsrc:group:3103mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Ecology']
concepts[field].anzsrc:group:3103mapping · dro deakin edu auvocabulary-mapper@1.0.0keywords['Ecology']
concepts[field].anzsrc:group:3103mapping · rdr ucl ac ukvocabulary-mapper@1.0.0keywords['Ecology']
concepts[field].anzsrc:group:3103mapping · figshare dmu ac ukvocabulary-mapper@1.0.0keywords['Ecology']
concepts[field].anzsrc:group:3104mapping · rdr ucl ac ukvocabulary-mapper@1.0.0keywords['Evolutionary Biology']
concepts[field].anzsrc:group:3104mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Evolutionary Biology']
concepts[field].anzsrc:group:3104mapping · dro deakin edu auvocabulary-mapper@1.0.0keywords['Evolutionary Biology']
concepts[field].anzsrc:group:3104mapping · figshare dmu ac ukvocabulary-mapper@1.0.0keywords['Evolutionary Biology']
concepts[field].anzsrc:group:3107mapping · figshare dmu ac ukvocabulary-mapper@1.0.0keywords['Microbiology']
concepts[field].anzsrc:group:3107mapping · dro deakin edu auvocabulary-mapper@1.0.0keywords['Microbiology']
concepts[field].anzsrc:group:3107mapping · rdr ucl ac ukvocabulary-mapper@1.0.0keywords['Microbiology']
concepts[field].anzsrc:group:3107mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Microbiology']
concepts[field].anzsrc:group:3204mapping · dro deakin edu auvocabulary-mapper@1.0.0keywords['Immunology']
concepts[field].anzsrc:group:3204mapping · figshare dmu ac ukvocabulary-mapper@1.0.0keywords['Immunology']
concepts[field].anzsrc:group:3204mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Immunology']
concepts[field].anzsrc:group:3204mapping · rdr ucl ac ukvocabulary-mapper@1.0.0keywords['Immunology']
concepts[field].local:field:earth-environmentalmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[field].local:field:earth-environmentalmapping · rdr ucl ac ukconnector:rdr_ucl_ac_uk@1.0.0
concepts[field].local:field:earth-environmentalmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:life-sciencesmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[field].local:field:life-sciencesmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:life-sciencesmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[field].local:field:life-sciencesmapping · rdr ucl ac ukconnector:rdr_ucl_ac_uk@1.0.0
concepts[field].local:field:medicine-healthmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:medicine-healthmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[field].local:field:medicine-healthmapping · rdr ucl ac ukconnector:rdr_ucl_ac_uk@1.0.0
concepts[field].local:field:medicine-healthmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[modality].local:modality:imageenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (65%)
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
licensesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/rights
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title